Ligand-independent phosphorylation of Y869 (Y845) links mutant EGFR signaling to stat-mediated gene expression
- 10 September 2007
- journal article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 314 (2), 413-419
- https://doi.org/10.1016/j.yexcr.2007.09.002
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesCancer Cell, 2006
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006
- Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptorsGenes & Development, 2006
- Signal Transducer and Activator of Transcription 5 (STAT5), a Crucial Regulator of Immune and Cancer CellsCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2005
- Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR MutantsPLoS Medicine, 2005
- Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle ProgressionCancer Research, 2005
- c-Src-mediated Phosphorylation of the Epidermal Growth Factor Receptor on Tyr845 and Tyr1101 Is Associated with Modulation of Receptor FunctionJournal of Biological Chemistry, 1999
- Mechanism of biological synergy between cellular Src and epidermal growth factor receptorProceedings of the National Academy of Sciences, 1999
- An Epidermal Growth Factor Receptor/Jak2 Tyrosine Kinase Domain Chimera Induces Tyrosine Phosphorylation of Stat5 and Transduces a Growth Signal in Hematopoietic CellsPublished by Elsevier BV ,1996
- c-SRC Phosphorylates Epidermal Growth Factor Receptor on Tyrosine 845Biochemical and Biophysical Research Communications, 1995